Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Internal Medicine
•
Gastroenterology
•
Advanced Endoscopy
Do you routinely use single-use duodenoscopes for ERCPs in patients with a history of infections secondary to MDR organisms?
Related Questions
What do you consider an optimal interval of time to repeat necrosectomies for treatment of WON?
Which patients would benefit from pancreatic duct stents in combination with rectal indomethacin for prophylaxis against post-ERCP pancreatitis?
What factors influence your choice of EMR vs ESD vs FTR for gastric neoplastic lesions?
Do you feel there is any difference between performing an ERCP with an EDGE together in a single session or separately in two sessions in a patient with Roux-en-Y anatomy?
In which patients do you recommend endoscopic bariatric procedures (such as endoscopic sleeve gastroplasty) instead of laparoscopic bariatric surgery?
How would you approach the workup of a patient with a history of HCC post-TARE with a recent non-viable MRI but a new portal vein thrombosis?
What sampling techniques do you use to improve the diagnostic yield of biopsies in a patient with suspected vasculitis and extensive scattered ulceration throughout the GI tract?
Is there a risk of hepatitis C activation with rituximab in a patient who has a history of HCV treated with antivirals and who is in sustained viral response?
When do you consider de-escalation from combination therapy with anti-TNFs and thiopurines to monotherapy with anti-TNFs in patients with IBD?
What is your approach to choosing a particular advanced therapy based on patient or disease factors when initiating treatment for moderate-severe IBD?
